Press Releases & Announcements

TEAM WOMEN

May 19, 2026

Q&A WITH BILL SHORT

May 19, 2026

Q&A WITH SHIBANI MUKERJI

May 19, 2026

THE RECIPIENTS OF THE 2025-2027 AESIMA ARE DR. PAULA DEBROY AND DR. EVELYN IRIARTE PARRA

Apr 24, 2026

ACTG LAUNCHES CRITICAL STUDY EVALUATING HORMONE THERAPY FOR WOMEN LIVING WITH HIV IN THE MENOPAUSE TRANSITION

Apr 24, 2026

ACTG ANNOUNCES PUBLICATION OF STOMP RESULTS IN THE NEW ENGLAND JOURNAL OF MEDICINE

Study findings do not support routine use of tecovirimat in people with mpox.

Feb 26, 2026

ACTG LAUNCHES IPACE-HIV TO STUDY FRAILTY INTERVENTION

ACTG is excited to undertake the first carefully controlled study evaluating senolytics as a potential intervention against frailty among people…

Jan 13, 2026

ACTG PRESENTS SLIM LIVER FINDINGS AT AASLD LIVER MEETING DEMONSTRATING IMPROVEMENTS IN BIOMARKERS OF CARDIOVASCULAR RISK AMONG PEOPLE LIVING WITH HIV AND MASLD WHO RECEIVE SEMAGLUTIDE

Nov 10, 2025

ACTG ANNUAL MEETING 2025 AWARD WINNERS

At ACTG, the annual memorial awards stand as enduring tributes to individuals whose names embody the very ideals and qualities…

Jul 29, 2025

ACTG PRESENTS STUDY AT CROI DEMONSTRATING INCREASED RISK OF OBESITY AND CARDIOMETABOLIC DISEASE AFTER SWITCH TO INTEGRASE INHIBITOR-CONTAINING REGIMEN

ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented data demonstrating that switching to…

Mar 17, 2025

ACTG PRESENTS IMPORTANT FINDINGS FROM REPRIEVE AT CROI 2025

ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented findings from the REPRIEVE trial…

Mar 17, 2025

ACTG PRESENTS STUDY AT CROI DEMONSTRATING POTENTIAL OF CMV-SPECIFIC ANTIVIRAL INHIBITOR TO IMPROVE AGING-RELATED OUTCOMES AMONG PEOPLE LIVING WITH HIV AND CMV (CYTOMEGALOVIRUS)

ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented promising findings from a study…

Mar 17, 2025